Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Seer Inc Cl A (NQ: SEER ) 2.060 UNCHANGED Streaming Delayed Price Updated: 4:00 PM EDT, Jul 25, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Seer Inc Cl A < Previous 1 2 3 4 5 Next > Seer to Report Second Quarter 2024 Financial Results on August 8, 2024 July 18, 2024 From Seer, Inc. Via GlobeNewswire Seer Proteograph™ Provides Differentiated Insights into Spaceflight Proteomic Alterations for Precision Medicine and Biomarker Discovery June 11, 2024 From Seer, Inc. Via GlobeNewswire Seer Technology Access Center Provides Unprecedented Scale and Depth of Coverage for PrognomiQ’s Early Cancer Detection Study June 02, 2024 Combined Workflow of Proteograph™ XT Assay and Thermo Scientific™ Orbitrap™ Astral™ Mass Spectrometer Robustly Identifies over 13,000 Protein Groups Across a Study of 2,840 Subjects From Seer, Inc. Via GlobeNewswire Recap: Seer Q4 Earnings February 29, 2024 Via Benzinga Earnings Scheduled For February 29, 2024 February 29, 2024 Companies Reporting Before The Bell • Frontline (NYSE:FRO) is expected to report quarterly earnings at $0.46 per share on revenue of $276.19 million. Via Benzinga Why Shares of Seer Are Slumping Wednesday August 09, 2023 The company reported a net loss but improved revenue in the second quarter. Via The Motley Fool SEER Stock Earnings: Seer Meets EPS, Misses Revenue for Q1 2024 May 08, 2024 SEER stock results show that Seer met analyst estimates for earnings per share but missed on revenue for the first quarter of 2024. Via InvestorPlace Seer Reports First Quarter 2024 Financial Results May 08, 2024 Demonstrated the power of the Proteograph Product Suite with a growing number of customer presentations and publications From Seer, Inc. Via GlobeNewswire Seer Launches New Technology Access Center in Europe to Expand Accessibility to Unbiased Proteomic Solutions May 08, 2024 From Seer, Inc. Via GlobeNewswire Seer to Report First Quarter 2024 Financial Results on May 8, 2024 April 23, 2024 From Seer, Inc. Via GlobeNewswire Seer Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Full Year 2024 Outlook February 29, 2024 Enhanced access to the Proteograph Product Suite and demonstrated its power with new customer data From Seer, Inc. Via GlobeNewswire Seer to Participate in the TD Cowen 44th Annual Health Care Conference February 21, 2024 From Seer, Inc. Via GlobeNewswire Zoom Video And 2 Other Stocks Insiders Are Selling February 08, 2024 The Nasdaq 100 closed higher by around 1% on Wednesday. Investors, meanwhile, focused on some notable insider trades. Via Benzinga Seer Proteograph™ Enables Unprecedented Genetic Marker Mapping for Proteogenomics Studies to Advance Drug and Biomarker Discovery February 06, 2024 From Seer, Inc. Via GlobeNewswire Seer to Report Fourth Quarter and Full Year 2023 Financial Results on February 29, 2024 February 01, 2024 From Seer, Inc. Via GlobeNewswire Seer to Present at the J.P. Morgan 42nd Annual Health Care Conference December 21, 2023 From Seer, Inc. Via GlobeNewswire Seer to Present at the Canaccord MedTech, Diagnostics and Digital Health & Services Forum November 10, 2023 From Seer, Inc. Via GlobeNewswire Seer Wins Proteomics Solution of the Year by BioTech Breakthrough and Named #5 on Deloitte Technology Fast 500 November 08, 2023 Seer technology receives recognition for excellence in the field of proteomics From Seer, Inc. Via GlobeNewswire Seer Reports Third Quarter 2023 Financial Results November 07, 2023 Expanded access to the Proteograph™ Product Suite through the Seer Technology Access Center, new distributors and a new Center of Excellence From Seer, Inc. Via GlobeNewswire Seer Announces Addition of Panome Bio to Centers of Excellence (COE) Program November 01, 2023 Panome Bio adds deep, unbiased proteomics to their proprietary metabolomics platform to deliver innovative multi-omics services From Seer, Inc. Via GlobeNewswire Seer to Report Third Quarter 2023 Financial Results on November 7, 2023 October 19, 2023 From Seer, Inc. Via GlobeNewswire Earnings Scheduled For November 7, 2023 November 07, 2023 Companies Reporting Before The Bell • CorEnergy Infr Tr (NYSE:CORR) is estimated to report earnings for its third quarter. Via Benzinga 7 Contrarian Stocks to Buy for the High-Stakes Gambler September 28, 2023 With limited options available as the market rotates out of risk-on assets, speculators may try their luck with contrarian stocks to buy. Via InvestorPlace Stocks That Hit 52-Week Lows On Thursday September 21, 2023 During the session on Thursday, 461 stocks hit new 52-week lows. Via Benzinga Seer to Participate in Upcoming September Investor Conferences September 08, 2023 From Seer, Inc. Via GlobeNewswire Stocks That Hit 52-Week Lows On Wednesday August 23, 2023 Wednesday's session saw 150 companies set new 52-week lows. Via Benzinga Stocks That Hit 52-Week Lows On Thursday August 10, 2023 On Thursday, 128 companies set new 52-week lows. Via Benzinga Why Cutera Shares Are Trading Lower By Around 22%? Here Are Other Stocks Moving In Wednesday's Session August 09, 2023 Gainers Tango Therapeutics, Inc. (NASDAQ: TNGX) climbed 85.2% to $7.09 after gaining 11% on Tuesday. Tango Therapeutics recently posted a narrower quarterly loss. Via Benzinga 12 Health Care Stocks Moving In Wednesday's Intraday Session August 09, 2023 Via Benzinga Seer Reports Second Quarter 2023 Financial Results August 08, 2023 Launched Proteograph XT Assay Kit, enabling rapid proteomics and large-scale studies From Seer, Inc. Via GlobeNewswire < Previous 1 2 3 4 5 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.